Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

  • Showing results for claudio zavaglia. Your search for Claudio Zabaglia retrieved no results.
1.

Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured?

Zavaglia C, Okolicsanyi S, Cesarini L, Mazzarelli C, Pontecorvi V, Ciaccio A, Strazzabosco M, Belli LS.

J Hepatol. 2017 Jan;66(1):236-237. doi: 10.1016/j.jhep.2016.08.016. Epub 2016 Aug 31. No abstract available.

PMID:
27592303
2.

Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: a systematic review and meta-analysis.

Mancuso A, Mazzola A, Cabibbo G, Perricone G, Enea M, Galvano A, Zavaglia C, Belli L, Cammà C.

Dig Liver Dis. 2015 Apr;47(4):324-30. doi: 10.1016/j.dld.2015.01.001. Epub 2015 Jan 12. Review.

PMID:
25641331
3.

Autoimmunity after liver transplantation: a frequent event but a rare clinical problem.

Foschi A, Zavaglia CA, Fanti D, Mazzarelli C, Perricone G, Vangeli M, Viganò R, Belli LS.

Clin Transplant. 2015 Feb;29(2):161-6. doi: 10.1111/ctr.12498. Epub 2015 Jan 8.

PMID:
25522890
4.

Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation: does mTOR inhibitors association augment toxicity?

Perricone G, Mancuso A, Belli LS, Mazzarelli C, Zavaglia C.

Eur J Gastroenterol Hepatol. 2014 May;26(5):577-8. doi: 10.1097/MEG.0000000000000073. No abstract available.

PMID:
24694739
5.

High-intensity focused ultrasound (HIFU) for the treatment of hepatocellular carcinoma: is it time to abandon standard ablative percutaneous treatments?

Zavaglia C, Mancuso A, Foschi A, Rampoldi A.

Hepatobiliary Surg Nutr. 2013 Aug;2(4):184-7. doi: 10.3978/j.issn.2304-3881.2013.05.02. No abstract available.

6.

Prognostic factors of hepatic decompensation and hepatocellular carcinoma in patients with transfusion-acquired HCV infection.

Zavaglia C, Silini E, Mangia A, Airoldi A, Piazzolla V, Vangeli M, Stigliano R, Foschi A, Mazzarelli C, Tinelli C.

Liver Int. 2014 Aug;34(7):e308-16. doi: 10.1111/liv.12502. Epub 2014 Mar 12.

PMID:
24529078
7.

Sorafenib efficacy for treatment of HCC recurrence after liver transplantation is an open issue.

Mancuso A, Mazzarelli C, Perricone G, Zavaglia C.

J Hepatol. 2014 Mar;60(3):681. doi: 10.1016/j.jhep.2013.10.030. Epub 2013 Nov 9. No abstract available.

8.

Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma.

Cammà C, Cabibbo G, Petta S, Enea M, Iavarone M, Grieco A, Gasbarrini A, Villa E, Zavaglia C, Bruno R, Colombo M, Craxì A; WEF study group; SOFIA study group.

Hepatology. 2013 Mar;57(3):1046-54. doi: 10.1002/hep.26221. Epub 2013 Feb 12.

PMID:
23299720
9.

Adverse events affect sorafenib efficacy in patients with recurrent hepatocellular carcinoma after liver transplantation: experience at a single center and review of the literature.

Zavaglia C, Airoldi A, Mancuso A, Vangeli M, Viganò R, Cordone G, Gentiluomo M, Belli LS.

Eur J Gastroenterol Hepatol. 2013 Feb;25(2):180-6. doi: 10.1097/MEG.0b013e328359e550. Review.

PMID:
23044808
10.

Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy.

Iavarone M, Cabibbo G, Piscaglia F, Zavaglia C, Grieco A, Villa E, Cammà C, Colombo M; SOFIA (SOraFenib Italian Assessment) study group.

Hepatology. 2011 Dec;54(6):2055-63. doi: 10.1002/hep.24644.

PMID:
21898496
11.

Ascites due to pericardial cyst.

Airoldi A, Zavaglia C, Vizzutti F, Vangeli M, Pinzello G.

Intern Emerg Med. 2009 Oct;4(5):449-50. doi: 10.1007/s11739-009-0274-z. Epub 2009 Jun 24. No abstract available.

PMID:
19551473
12.

Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?

Zavaglia C, Corso R, Rampoldi A, Vinci M, Belli LS, Vangeli M, Solcia M, Castoldi C, Prisco C, Vanzulli A, Pinzello G.

Eur J Gastroenterol Hepatol. 2008 Mar;20(3):196-201. doi: 10.1097/MEG.0b013e3282f1cc4a.

PMID:
18301300
13.

A phase II study of tegafur plus uracil or tegafur alone for the treatment of advanced hepatocellular carcinoma.

Zavaglia C, Prisco C, Pinzello G.

Eur J Gastroenterol Hepatol. 2008 Jan;20(1):87-8. No abstract available.

PMID:
18090998
14.

Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.

Belli LS, Burroughs AK, Burra P, Alberti AB, Samonakis D, Cammà C, De Carlis L, Minola E, Quaglia A, Zavaglia C, Vangeli M, Patch D, Dhillon A, Cillo U, Guido M, Fagiuoli S, Giacomoni A, Slim OA, Airoldi A, Boninsegna S, Davidson BR, Rolles K, Pinzello G.

Liver Transpl. 2007 May;13(5):733-40.

15.

HLA-DRB1 donor-recipient mismatch affects the outcome of hepatitis C disease recurrence after liver transplantation.

Belli LS, Burra P, Poli F, Battista Alberti A, Silini E, Zavaglia C, Fagiuoli S, Prando D, Espadas de Arias A, Boninsegna S, Tinelli C, Scalamogna M, de Carlis L, Pinzello G.

Gastroenterology. 2006 Mar;130(3):695-702.

PMID:
16530511
16.

Predictors of long-term survival after liver transplantation for hepatocellular carcinoma.

Zavaglia C, De Carlis L, Alberti AB, Minola E, Belli LS, Slim AO, Airoldi A, Giacomoni A, Rondinara G, Tinelli C, Forti D, Pinzello G.

Am J Gastroenterol. 2005 Dec;100(12):2708-16.

PMID:
16393224
17.

Codon 72 polymorphism of P53 gene does not affect the risk of cirrhosis and hepatocarcinoma in HCV-infected patients.

Leveri M, Gritti C, Rossi L, Zavaglia C, Civardi E, Mondelli MU, De Silvestri A, Silini EM.

Cancer Lett. 2004 May 10;208(1):75-9.

PMID:
15105048
18.

Genetic polymorphisms of steroid hormone metabolizing enzymes and risk of liver cancer in hepatitis C-infected patients.

Rossi L, Leveri M, Gritti C, De Silvestri A, Zavaglia C, Sonzogni L, Silvestri L, Civardi E, Mondelli MU, Silini EM.

J Hepatol. 2003 Oct;39(4):564-70.

PMID:
12971967
19.

CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer.

Silvestri L, Sonzogni L, De Silvestri A, Gritti C, Foti L, Zavaglia C, Leveri M, Cividini A, Mondelli MU, Civardi E, Silini EM.

Int J Cancer. 2003 Apr 10;104(3):310-7.

20.

Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease.

Sonzogni L, Silvestri L, De Silvestri A, Gritti C, Foti L, Zavaglia C, Bottelli R, Mondelli MU, Civardi E, Silini EM.

Hepatology. 2002 Jul;36(1):195-201.

PMID:
12085365

Supplemental Content

Loading ...
Support Center